3D Printing and Bioprinting Applications in Pharmaceutics

Dear Colleagues,

The 3D printing (3DP) process was patented in 1986; however, only in the last decade has it been used for medical applications, as well as being utilised in the fields of bio-fabrication and pharmaceutical printing.  3DP or additive manufacturing (AM) permits the fabrication of high degrees of complexity with great reproducibility, in a fast and cost-effective fashion. The term involves many processes, which use different types of printing technologies, hundreds of materials, and various resolutions and speeds. 3DP techniques can be used in pharmaceutical fields isuch as stereolithography (SLA), selective laser sintering (SLS), inkjet-based 3DP, extrusion-based fused deposition modeling (FDM), and pressure-assisted microsyringe (PAM) printing. 3DP allows the manufacturing of complex drug delivery devices and seems to be a pragmatic approach to realise the quest for a truly customised and personalised drug delivery. 3DP technology, with innovations in pharmaceutical development and an interdisciplinary approach to finding newer drug-delivery systems, can usher in a new era of treatments to various diseases. This collection invites papers in the area of 3DP and bioprinting for pharmaceutical applications, covering recent advantages and future directions of AM for pharmaceutical products, including regulatory considerations and modelling approaches. Original research papers and review articles are welcome.

Dr. Dimitrios A. Lamprou
Dr. Eneko Larrañeta
Collection Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.